← FDA Drug Approvals (Drugs@FDA)

TYVASO

NDA · New Drug Application · Sponsor: UNITED THERAP · Approved 2009-07-30

Drug application

FDA Application #

NDA022387

Application type

New Drug Application

Brand name

TYVASO

Generic name

TREPROSTINIL

Active ingredients

TREPROSTINIL

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Prescription

Sponsor

UNITED THERAP

Manufacturer

United Therapeutics Corporation

First approval

2009-07-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown